Literature DB >> 11289040

Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice.

P P Chiu1, D V Serreze, J S Danska.   

Abstract

Insulin-dependent diabetes (type 1 diabetes) in the NOD mouse is a T-cell-mediated autoimmune disease. However, B-cells may also play a critical role in disease pathogenesis, as genetically B-cell-deficient NOD mice (NOD.microMT) have been shown to be protected from type 1 diabetes and to display reduced responses to certain islet autoantigens. To examine the requirements for B-cells in the development of type 1 diabetes, we generated a B-cell-naive T-cell repertoire by transplantation of NOD fetal thymuses (FTs) into NOD.scid recipients. Surprisingly, these FT-derived NOD T-cells were diabetogenic in 36% of NOD.scid recipients, despite the absence of B-cells. In addition, T-cells isolated from NOD.microMT mice were diabetogenic in 22% of NOD.scid recipients. Together, these results indicate that B-cells are not an absolute requirement for the generation or effector function of an islet-reactive T-cell repertoire in NOD mice. We suggest that conditions favoring rapid lymphocyte expansion can reveal autoreactive T-cell activity and precipitate disease in genetically susceptible individuals.

Entities:  

Mesh:

Year:  2001        PMID: 11289040     DOI: 10.2337/diabetes.50.4.763

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Authors:  Takashi Matsushita; Koichi Yanaba; Jean-David Bouaziz; Manabu Fujimoto; Thomas F Tedder
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

2.  The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.

Authors:  Alexandra I Ziegler; Melanie A Le Page; Mhairi J Maxwell; Jessica Stolp; Haoyao Guo; Abhirup Jayasimhan; Margaret L Hibbs; Pere Santamaria; Jacques F Miller; Magdalena Plebanski; Pablo A Silveira; Robyn M Slattery
Journal:  Diabetologia       Date:  2013-09-08       Impact factor: 10.122

3.  B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.

Authors:  I Ueki; N Abiru; M Kobayashi; M Nakahara; T Ichikawa; K Eguchi; Y Nagayama
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 4.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 5.  B cell depletion in autoimmune diabetes: insights from murine models.

Authors:  Jayne L Chamberlain; Kesley Attridge; Chun Jing Wang; Gemma A Ryan; Lucy Sk Walker
Journal:  Expert Opin Ther Targets       Date:  2011-03-03       Impact factor: 6.902

6.  B cells in autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2005-11-10

7.  B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.

Authors:  Pablo A Silveira; Joseph Dombrowsky; Ellis Johnson; Harold D Chapman; David Nemazee; David V Serreze
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

8.  In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice.

Authors:  Ghazal Zekavat; Susan Y Rostami; Armen Badkerhanian; Ronald F Parsons; Brigitte Koeberlein; Ming Yu; Christopher D Ward; Thi-Sau Migone; Liping Yu; George S Eisenbarth; Michael P Cancro; Ali Naji; Hooman Noorchashm
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 9.  Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice.

Authors:  Y Yang; P Santamaria
Journal:  Diabetologia       Date:  2003-10-28       Impact factor: 10.122

10.  B1 cells promote pancreas infiltration by autoreactive T cells.

Authors:  Gemma A Ryan; Chun Jing Wang; Jayne L Chamberlain; Kesley Attridge; Emily M Schmidt; Rupert Kenefeck; Louise E Clough; Kyri Dunussi-Joannopoulos; Kai-Michael Toellner; Lucy S K Walker
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.